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tet(W) was found responsible for tetracycline resistance (MICs, 4 to >32 g ml1) in dominant bifidobac-
terial species from the gastrointestinal tracts of healthy humans. The gene from Bifidobacterium longum H66
proved to be identical over a 2.6-kbp region to the recently described tet(W) determinant of Butyrivibrio
fibrisolvens.
The commensal intestinal microbiota of humans and an-
imals may act as a reservoir of antibiotic resistance genes
that could ultimately be transferred to pathogens (15, 18); in
fact, gene transfer between bacterial species in the gastro-
intestinal tracts (GIT) of mammals is known to occur (11).
Bifidobacteria are among the dominant populations of the
human GIT microbiota, where they are thought to play a
pivotal role in maintaining the microbial balance necessary
for intestinal health (19). Bifidobacterial strains are there-
fore frequently used as probiotics in the prophylaxis and
therapy of GIT disorders (12). This practice, however, re-
quires that they be screened for acquired antibiotic resis-
tance determinants if the latter are not to be propagated
through the food chain (14, 15, 18).
Tetracyclines inhibit protein synthesis by preventing the at-
tachment of aminoacyl-tRNA to the bacterial ribosome (2).
The broad-spectrum antimicrobial properties of these agents,
the absence of major adverse side effects, and their low price
have led to their intensive use not only in the treatment of
human and animal infections but also as prophylactic agents
and growth promoters in livestock raising and aquaculture (2).
This extensive use has promoted the appearance of resistance
and its spread by horizontal acquisition (2, 13). Resistance is
mediated through efflux proteins, ribosomal protection pro-
teins, or antibiotic-inactivating enzymes (for a review, see
reference 13).
The tet(W) gene, which encodes a ribosomal protection pro-
tein, has recently been described for a wide range of gram-positive
and gram-negative bacteria (1, 2), including bifidobacteria (7, 10,
17). This gene has been associated with a conjugative transposon
(TnB1230) in Butyrivibrio fibrisolvens (9) that has been shown to
transfer at high frequencies (up to 5.1 103 transconjugants per
recipient) (16).
In a recent survey, a microbroth assay showed atypical (16
g ml1) MICs of tetracycline for human bifidobacterial
strains isolated from fecal samples of healthy adults without a
recent history of antibiotic treatment (4). The object of this
study was to investigate the nature and molecular organization
of the tetracycline determinant encoding this resistance.
MICs of tetracycline for bifidobacteria. The MICs of tetra-
cycline for a series of susceptible (14 isolates) and resistant (16
isolates) bifidobacterial species which had been assayed by
microdilution (4) were precisely determined by Etest (AB Bio-
disk, Solna, Sweden). Assays were performed in LSM test agar
(6) (90% IsoSensitest, 10% MRS, 1.5% agar; all from Oxoid,
New Hampshire, United Kingdom) supplemented with 0.3 g of
cysteine liter1. Plates were incubated at 37°C for 48 h in an
anaerobic chamber (atmosphere, 10% H2–10% CO2–80% N2).
The MICs for susceptible isolates ranged from 0.25 to 1 g
ml1, whereas those for isolates thought to be resistant ranged
from 4 to 32 g ml1. MICs obtained for the same strains in
duplicate experiments never exceeded 1 order of dilution.
To exclude the analysis of replicates, resistant and suscepti-
ble isolates were typed by rapid amplification of polymorphic
DNA (RAPD) analysis by PCR. Amplifications were per-
formed using primer OPA18 and PCR conditions described
elsewhere (8). Seven different RAPD-PCR profiles identifying
distinct strains were obtained among the resistant isolates, as
follows: Bifidobacterium longum (11 isolates, 5 strains), Bifido-
bacterium bifidum (5 isolates, 1 strain), and Bifidobacterium
animalis subsp. animalis (1 isolate, 1 strain).
Amplification and analysis of tetracycline resistance genes.
The presence of genes encoding ribosomal protection proteins
was checked among resistant and susceptible strains by PCR
with two pairs of degenerate primers: DI–DII (3) and Tet1–
Tet2 (1). Resistant strains all yielded a single PCR product of
the same size when either of the primer pairs was used. Sur-
prisingly, positive amplification was also obtained with DNA
from the susceptible strain B. longum M21. Additional PCR
assays were then performed with primers TetWF and Tet2,
specific for tet(W) (17), and primers DI and TetMR, specific
for tet(M) (5). No DNA was amplified from either resistant or
susceptible isolates with primers for tet(M). In contrast, a prod-
uct of about 1,250 bp was obtained for all 16 resistant isolates
when primers for tet(W) were used. Purified amplicons were
sequenced and the resulting sequences analyzed and compared
to others held in public databases.
Analysis of the nucleotide sequences showed them to share
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99.8% identity. Comparison of the sequences showed a high
degree of similarity at the nucleotide level to several tetracy-
cline resistance genes. In particular, complete identity was seen
with an internal segment of the tet(W) gene from B. fibrisolvens
(1). Based on this homology, primers TetWSacF (5-CCCTG
GAGCTCATGCTCATGTAC-3) and TetWSacR (5-CCAT
CGGAGCTCCATAACTTCTG-3) were designed to amplify
the whole gene and its surrounding promoter and terminator
regions. Positive amplification was obtained only when DNA
from the resistant strains was used as a template, suggesting
that the susceptible strain may harbor a shortened (nonfunc-
tional) version of the gene.
The amplicon was cloned into pUC19 and introduced into
Escherichia coli, which became resistant to tetracycline (MIC,
64 g ml1). The insert was then double-strand sequenced. At
the nucleotide level, analysis of a 2,589-bp segment showed
that the sequence was identical to that of B. fibrisolvens 1.230
(1, 9), except for a single oligonucleotide change in the coding
region leading to a conservative amino acid replacement in its
deduced Tet(W) protein. Further, the B. longum H66 sequence
was found to share around 98% identity to recently reported
tet(W) genes from bifidobacterial species (GenBank accession
no. AF202986) (7, 17). A phylogenetic tree showing the rela-
tionships of the deduced Tet(W) proteins and those of other
ribosome protection proteins is depicted in Fig. 1. The pres-
ence of resistance genes with nearly identical nucleotide and
protein sequences in unrelated bacterial and bifidobacterial
species suggests that recent horizontal transfer has occurred
(1, 16). Intriguing is the fact that different MICs are repeatedly
reported for identical genes (7, 10, 17). Multiple loci, different
expression levels of tet(W), and/or the influence of the genetic
background of the strains may account for the phenotypic
differences.
Location of the tet(W) gene. The genetic location of tet(W) in
the distinct species was assessed by hybridization using as a
probe a 1.2-kbp internal segment of the gene obtained by PCR
and labeled with digoxigenin (Roche Applied Science, Basel,
Switzerland). Total and plasmid DNAs digested with the re-
striction enzymes EcoRI and HindIII (Roche) were hybridized
using high-stringency standard conditions (hybridization at
68°C and two final washing steps in 0.5 SSC [1 SSC is 0.15
M NaCl plus 0.015 M sodium citrate]–0.1% SDS at 68°C for 15
min). Figure 2 shows the results obtained with EcoRI-digested
total DNA. A positive hybridization signal was obtained with
all tetracycline-resistant strains and, as expected, with the sus-
ceptible strain M21. The hybridization signal appeared at a
different position in each of the strains (estimated sizes, 2.5 to
16 kbp), except for the related strains B. longum B93 and B94
(displaying distinct RAPD-PCR patterns but isolated from the
same individual). This suggests that the genetic organization of
the loci might be different in each strain. The tet(W) locus is
thought to be located on the bacterial chromosome, since only
FIG. 1. Phylogenetic tree showing the evolutionary relationships of complete Tet(W) and other ribosome protection proteins from tetracycline-
resistant bacteria. GenBank accession numbers for the nucleotide sequences used to derive amino acid sequences are given in parentheses. The
rooted neighbor-joining tree was generated using DNAman software (Lynnon Corporation, Vaudreuil-Dorion, Quebec, Canada). Numbers beside
nodes indicate bootstrap values when these are greater than 95% (based on 500 trials). Bar, 0.05% difference in amino acid sequence.
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the resistant strain B. bifidum L71 was shown to harbor a
plasmid (of around 15 kbp), and its hybridization signals did
not match the position of EcoRI and HindIII plasmid frag-
ments (data not shown).
Since the tet(W) gene is encoded on a conjugative transpo-
son in B. fibrisolvens 1.230 (TnB1230) (9, 17), primers based on
transposon sequences were also synthesized and used in PCR
experiments. However, no amplification products were ob-
tained with any strain, suggesting that there are no sequences
related to this mobile unit in these Bifidobacterium species.
Further, preliminary inverse-PCR experiments indicate that
tet(W) is inserted into a putative open reading frame encoding
a permease (GenBank accession no. AE014295) of an ABC
transporter system in B. longum NCC2705 (data not shown).
In conclusion, these and other results indicate that dominant
Bifidobacterium species from the human GIT frequently har-
bor acquired tetracycline resistance encoded by a tet(W) gene.
The fact that genes from Bifidobacterium showed more nucle-
otide changes than those from species of different genera
strongly suggests independent transfer events. The spread of
this gene among cattle rumen and human GIT organisms may
be occurring very rapidly by unknown mechanisms that merit
further research. However, preliminary conjugation experi-
ments showed that tetracycline resistance from B. longum H66
and L42 did not transfer to susceptible strains (data not
shown). Once acquired, genes could either be stably main-
tained in the absence of antibiotic selection or selected by
continued exposure to antibiotics through dietary intake (5).
Nucleotide sequence accession number. The nucleotide se-
quence of the tet(W) gene and its surrounding regions from B.
longum H66 has been deposited in GenBank (accession no.
DQ060146).
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FIG. 2. Hybridization of EcoRI-digested chromosomal DNA from
different Bifidobacterium strains using a 1.2-kbp PCR amplicon ob-
tained with the specific primers for tet(W) as a probe. The code num-
bers of the strains are given above the lane numbers. Tetracycline-
susceptible strains are asterisked. Lanes 1, 2, 3, 4, 5, 6, and 7,
Bifidobacterium longum strains; lane 8, Bifidobacterium animalis E43;
lanes 9 and 10, Bifidobacterium bifidum strains. Lanes M, molecular
weight marker (digoxigenin-labeled, EcoRI- and HindIII-digested
lambda DNA).
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